KSRP is Critical in Governing Hepatic Lipid Metabolism Through Controlling Per2 Expression
Overview
Affiliations
Hepatic lipid metabolism is controlled by integrated metabolic pathways. Excess accumulation of hepatic TG is a hallmark of nonalcoholic fatty liver disease, which is associated with obesity and insulin resistance. Here, we show that KH-type splicing regulatory protein (KSRP) ablation reduces hepatic TG levels and diet-induced hepatosteatosis. Expression of period 2 (Per2) is increased during the dark period, and circadian oscillations of several core clock genes are altered with a delayed phase in Ksrp(-/-) livers. Diurnal expression of some lipid metabolism genes is also disturbed with reduced expression of genes involved in de novo lipogenesis. Using primary hepatocytes, we demonstrate that KSRP promotes decay of Per2 mRNA through an RNA-protein interaction and show that increased Per2 expression is responsible for the phase delay in cycling of several clock genes in the absence of KSRP. Similar to Ksrp(-/-) livers, both expression of lipogenic genes and intracellular TG levels are also reduced in Ksrp(-/-) hepatocytes due to increased Per2 expression. Using heterologous mRNA reporters, we show that the AU-rich element-containing 3' untranslated region of Per2 is responsible for KSRP-dependent mRNA decay. These findings implicate that KSRP is an important regulator of circadian expression of lipid metabolism genes in the liver likely through controlling Per2 mRNA stability.
Li M, Fang Q, Xiao P, Yin Z, Mei G, Wang C Cell Death Dis. 2024; 15(8):618.
PMID: 39187547 PMC: 11347664. DOI: 10.1038/s41419-024-06886-1.
Olguin S, Patel P, Buchanan C, DellOrco M, Gardiner A, Cole R Commun Biol. 2022; 5(1):672.
PMID: 35798971 PMC: 9262970. DOI: 10.1038/s42003-022-03594-4.
CNOT1 regulates circadian behaviour through mRNA decay in a deadenylation-dependent manner.
Mohamed H, Takahashi A, Nishijima S, Adachi S, Murai I, Okamura H RNA Biol. 2022; 19(1):703-718.
PMID: 35510877 PMC: 9090297. DOI: 10.1080/15476286.2022.2071026.
Dolicka D, Sobolewski C, Correia de Sousa M, Gjorgjieva M, Foti M Int J Mol Sci. 2020; 21(18).
PMID: 32932781 PMC: 7554771. DOI: 10.3390/ijms21186648.
KSRP modulates melanoma growth and efficacy of vemurafenib.
Liu W, Chou C, Liu S, Crossman D, Yusuf N, Wu Y Biochim Biophys Acta Gene Regul Mech. 2019; 1862(8):759-770.
PMID: 31269460 PMC: 7446395. DOI: 10.1016/j.bbagrm.2019.06.005.